{
    "clinical_study": {
        "@rank": "3174", 
        "arm_group": [
            {
                "arm_group_label": "Glucosamine sulfate & Diacerein", 
                "arm_group_type": "Experimental", 
                "description": "Glucosamine sulfate (sachet) 1500 mg and Diacerein 50 mg tablet by mouth once daily for 24 weeks"
            }, 
            {
                "arm_group_label": "Glucosamine sulfate & Placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "Glucosamine sulfate 1500 mg and Placebo (for Diacerein) 50 mg by mouth once daily for 24 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare pain scores, WOMAC total and subscores, actual and\n      change of joint space width and the rate of gastrointestinal side effects at 4, 8, 12, and\n      24 weeks between dual-therapy of  diacerein and glucosamine versus a mono-therapy of\n      glucosamine in OA patients"
        }, 
        "brief_title": "Clinical Efficacy of Glucosamine Plus Diacerein Versus Mono-therapy of Glucosamine", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Osteoarthritis", 
            "Glucosamine", 
            "Diacerein"
        ], 
        "condition_browse": {
            "mesh_term": "Osteoarthritis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Adult patients age 50 years or older who have been diagnosed as primary or secondary\n        osteoarthritis of the knee base on clinical criteria  of American College of Rheumatology\n\n        Inclusion Criteria:\n\n          -  Clinical diagnosis of primary osteoarthritis\n\n          -  Mild deformity Clinical (having no varus or valgus deformity, no crepitus) ? Physical\n             examination grade 0 assessed by stress test Radiographic assessment\n             (Kellgrane-lawrance type II-III), a minimum baseline medial tibiofemoral JSW of _2\n             mm.\n\n          -  Willing to participate and provide written informed consent\n\n        Exclusion Criteria:\n\n          -  Non-secondary osteoarthritis Rheumatoid arthritis,  inflammatory arthritis (e.g. SLE,\n             Gout),  post traumatic osteoarthritis, those who received intra-articular treatment\n             of the signal joint with any product (corticosteroids in the previous 2 months, or\n             glycosaminoglycans/hyaluronic acid in the previous 6 months) or had undergone joint\n             lavage andarthroscopic procedures in the previous 6 months.\n\n          -  No contraindication of using diacerein and glucosamine\n\n          -  Non-current or ex-users of oral SYSADOA (e.g., glucosamine sulphate, chondroitin\n             sulphate, diacerein, piascledine), anti-depressants, tranquillisers, antacids or\n             antibiotics known hypersensitivity to diacerein, to similar compounds, to the\n             excipients or to paracetamol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "148", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01906801", 
            "org_study_id": "04-56-25"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Glucosamine sulfate & Diacerein", 
                    "Glucosamine sulfate & Placebo"
                ], 
                "intervention_name": "Glucosamine sulfate", 
                "intervention_type": "Drug", 
                "other_name": "Viatril-S"
            }, 
            {
                "arm_group_label": "Glucosamine sulfate & Diacerein", 
                "intervention_name": "Diacerein", 
                "intervention_type": "Drug", 
                "other_name": "Artrodar"
            }, 
            {
                "arm_group_label": "Glucosamine sulfate & Placebo", 
                "description": "Sugar pill manufactured to mimic Diacerein 50 mg tablet", 
                "intervention_name": "Placebo (for Diacerein)", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Diacetylrhein"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Osteoarthritis", 
            "Glucosamine sulfate", 
            "Diacerein", 
            "Randomized controlled trial"
        ], 
        "lastchanged_date": "July 23, 2013", 
        "location": {
            "contact": {
                "email": "Siwadolra@hotmail.com", 
                "last_name": "Siwadol Wongsak, MD", 
                "phone": "+66819003177"
            }, 
            "contact_backup": {
                "email": "sudasiri.sri@mahidol.ac.th", 
                "last_name": "Sudasiri Sriwiang", 
                "phone": "+6622012684"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10400"
                }, 
                "name": "Department of Orthopaedics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Mahidol University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "Jatupon_kong@hotmail.com", 
            "last_name": "Jatupon Kongtharvonskul, MD", 
            "phone": "+66896675440"
        }, 
        "overall_contact_backup": {
            "email": "ammarin.tak@mahidol.ac.th", 
            "last_name": "Ammarin Thakkinstian, Ph.D"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Orthopaedics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Mahidol University, Thailand.", 
                "last_name": "Patarawan Woratanarat, MD, Ph.D", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand", 
                "last_name": "Ammarin Thakkinstian, Ph.D", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "pain visual analog scores", 
            "safety_issue": "No", 
            "time_frame": "24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01906801"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ramathibodi Hospital", 
            "investigator_full_name": "Jatupon Kongtharvonskul", 
            "investigator_title": "Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Western Ontario and McMaster Universities Osteoarthritis (WOMAC) scores", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "actual and change of joint space width", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Rate of gastrointestinal side effects", 
                "safety_issue": "Yes", 
                "time_frame": "24 weeks"
            }
        ], 
        "source": "Ramathibodi Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ramathibodi Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}